UBS has raised Aptiv PLC's target price to €66 from €58 while maintaining a Neutral rating, as the company reported first-quarter results that exceeded expectations. Despite market uncertainties and tariff concerns, Aptiv's solid guidance for the second quarter and full-year projections reflect resilience, with adjusted earnings per share expected between €7.00 and €7.60. The stock, currently trading at €59.29, is viewed as undervalued, supported by upward revisions in earnings estimates from analysts.